Who invested in Epsilogen?
Epsilogen's investors include Innovate UK, Novartis and AlbionVC.
United Kingdom · Series B startup
5 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$97Mraised across 5 rounds since 2022, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Epsilogen's investors include Innovate UK, Novartis and AlbionVC.
Epsilogen has raised $97M across 5 rounds since 2022.
Epsilogen's most recent round was a Series B of $14M in Aug 2025.
Epsilogen's largest round on record is $37M (Series B), in Mar 2025.
Epsilogen's first round on record, in Sept 2024, was backed by Innovate UK, Novartis and AlbionVC.
Epsilogen's latest named round is a Series B, in Aug 2025.
Epsilogen is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.